Td Private Client Wealth LLC Vertex Pharmaceuticals Inc Transaction History

Td Private Client Wealth LLC

$3.48 Trillion
Q3 2024

A detailed history of Td Private Client Wealth LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 13,687 shares of VRTX stock, worth $5.47 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

13,687

Previous 10,193 34.28%

Holding current value

$5.47 Million

Previous $4.78 Billion 33.24%

% of portfolio

0.18%

Previous 0.15%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 18, 2024	BUY	$460.0 - $505.78 $1.61 Million - $1.77 Million	3,494 Added 34.28%	13,687 $6.37 Billion
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $4 Million - $4.95 Million	10,193 New	10,193 $4.78 Billion
Q1 2024 Aug 16, 2024	SELL	$407.69 - $446.08 $434,189 - $475,075	-1,065 Reduced 7.67%	12,816 $5.36 Billion
Q4 2023 Aug 16, 2024	SELL	$343.0 - $410.68 $417,088 - $499,386	-1,216 Reduced 8.05%	13,881 $5.65 Billion
Q3 2023 Aug 16, 2024	SELL	$338.18 - $362.46 $333,107 - $357,023	-985 Reduced 6.12%	15,097 $5.25 Billion
Q2 2023 Aug 16, 2024	SELL	$314.42 - $351.91 $337,372 - $377,599	-1,073 Reduced 6.25%	16,082 $5.66 Billion
Q1 2023 Aug 16, 2024	BUY	$283.23 - $323.1 $578,638 - $660,093	2,043 Added 13.52%	17,155 $5.41 Billion
Q4 2022 Aug 16, 2024	SELL	$285.76 - $321.48 $42,578 - $47,900	-149 Reduced 0.98%	15,112 $4.36 Billion
Q3 2022 Aug 16, 2024	SELL	$273.83 - $305.53 $137,736 - $153,681	-503 Reduced 3.19%	15,261 $4.42 Billion
Q2 2022 Aug 16, 2024	BUY	$234.96 - $292.55 $1.12 Million - $1.39 Million	4,750 Added 43.13%	15,764 $4.44 Billion
Q1 2022 Aug 16, 2024	BUY	$221.42 - $260.97 $68,197 - $80,378	308 Added 2.88%	11,014 $2.87 Billion
Q4 2021 Aug 16, 2024	SELL	$177.01 - $223.45 $114,879 - $145,019	-649 Reduced 5.72%	10,706 $2.35 Billion
Q3 2021 Aug 16, 2024	BUY	$181.39 - $202.99 $210,775 - $235,874	1,162 Added 11.4%	11,355 $2.06 Billion
Q2 2021 Aug 16, 2024	BUY	$187.49 - $221.1 $1.22 Million - $1.44 Million	6,516 Added 897.52%	7,242 $1.46 Billion
Q1 2021 Aug 16, 2024	SELL	$207.02 - $241.31 $1.6 Million - $1.87 Million	-7,733 Reduced 91.42%	726 $156 Million
Q4 2020 Aug 16, 2024	SELL	$207.01 - $276.09 $406,153 - $541,688	-1,962 Reduced 18.83%	8,459 $2 Billion
Q3 2020 Aug 16, 2024	BUY	$255.65 - $303.1 $16,617 - $19,701	65 Added 0.63%	10,421 $2.84 Billion
Q2 2020 Aug 16, 2024	BUY	$225.48 - $295.8 $2.16 Million - $2.83 Million	9,580 Added 1234.54%	10,356 $3.01 Billion
Q1 2020 Aug 16, 2024	BUY	$199.77 - $247.81 $23,572 - $29,241	118 Added 17.93%	776 $185 Million
Q4 2019 Aug 16, 2024	SELL	$166.71 - $223.91 $1.59 Million - $2.13 Million	-9,535 Reduced 93.54%	658 $144 Million

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $103B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Vertex Pharmaceuticals Inc Transaction History